Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05258487 · ClinicalTrials.gov registry record
The Utility of the Validated Intraoperative Bleeding Scale in Spine Surgery
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 121
- Enrollment target
NCT05258487: Completed study, sponsored by University of Maryland, Baltimore.
NCT05258487 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 121 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05258487 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 121 participants
- Enrollment target
Study Summary
This is a single-center, prospective, observational study that will compare the blood transfusion rate between intraoperative bleeding severity characterized using the Validated Intraoperative Bleeding Scale (VIBe).
Primary Outcome
The main outcome will be whether or not the patient received a blood transfusion during the surgery or the postoperative hospitalization period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2023-03-14 |
What the finished NCT05258487 record still lists
NCT05258487 is an observational study that tracks outcomes without assigning an intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05258487 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05258487 about?
NCT05258487 is a clinical study titled "The Utility of the Validated Intraoperative Bleeding Scale in Spine Surgery". This is a single-center, prospective, observational study that will compare the blood transfusion rate between intraoperative bleeding severity characterized using the Validated Intraoperative Bleeding Scale (VIBe).
What is the current status of trial NCT05258487?
This trial is currently completed. The enrollment target is 121 participants. The study started on 2022-03-01. Estimated completion is 2023-03-14.
Who is sponsoring clinical trial NCT05258487?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI